Warning letter
Edrugnet.com/1accutane.com: warning letter of Sep 9, 2003
FDA warning letter UCM147702 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM147702 |
|---|---|
| Company | Edrugnet.com/1accutane.com |
| Subject | New Drug/Labeling/False Promotional Statements/Misbranded |
| Issue date | Sep 9, 2003 |
| Posted date | Sep 9, 2003 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 201.115 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: